Ajanta Competitors

AJANTPHARM   3,027  30.05  1.00%   
  
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ajanta Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3,0263,0283,030
Details
Intrinsic
Valuation
LowRealHigh
2,7222,7243,329
Details
Naive
Forecast
LowNextHigh
3,1173,1193,122
Details
Earnings
Estimates (0)
LowProjected EPSHigh
18.1018.1018.10
Details

Ajanta Pharma Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ajanta Pharma and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Ajanta and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ajanta Pharma Limited does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
FOODSINVERTOZ
LTFOODSMEDIASSIST
FOODSINLTFOODS
FOODSINMEDIASSIST
SARVESHWARMEDIASSIST
MEDIASSISTKOHINOOR
  
High negative correlations   
ADFFOODSVERTOZ
FOODSINADFFOODS
ADFFOODSMEDIASSIST
ADFFOODSLTFOODS
ADFFOODSSARVESHWAR
ADFFOODSKOHINOOR

Risk-Adjusted Indicators

There is a big difference between Ajanta Stock performing well and Ajanta Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ajanta Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Ajanta Pharma Limited and related stocks such as Kohinoor Foods, MEDI ASSIST HEALTHCARE, and Sarveshwar Foods Net Income Over Time
201020112012201320142015201620172018201920202021202220232024
KOHINOOR212.6 M1.9 B97.4 M231.3 M(944.2 M)(239.3 M)(1.4 B)(803.6 M)(4.2 B)(1.8 B)242.3 M(63.2 M)(41.4 M)(45.5 M)(47.8 M)
MEDIASSIST335.5 M335.5 M335.5 M335.5 M335.5 M335.5 M335.5 M335.5 M335.5 M262.7 M642.2 M740.4 M669.4 M769.8 M583.1 M
SARVESHWAR55 M55 M55 M72.1 M77.9 M54.8 M128.7 M165.1 M181 M57.1 M52.4 M59.8 M77.9 M2.8 B2.9 B
LTFOODS210 M(20.1 M)560.5 M783.3 M724.9 M721.1 M1.2 B1.3 B1.3 B1.8 B2.7 B2.9 BB5.9 B6.2 B
VERTOZ3.6 M3.6 M3.6 M3.6 M3.6 M3.6 M30.6 M57.4 M73.4 M40.5 M81.8 M61 M110.4 M157.8 M165.7 M
ADFFOODS63.9 M61.2 M140.4 M56.5 M88.4 M66.1 M108.4 M180.7 M253.3 M427.7 M500.7 M481 M561 M752.9 M790.5 M
FOODSIN62.2 M25.1 M25.1 M53.1 M124.9 M5.6 M73.8 M34.7 M1.1 B110.9 M39.3 M152.9 M474.1 M367.2 M206.8 M

Ajanta Pharma Limited and related stocks such as Kohinoor Foods, MEDI ASSIST HEALTHCARE, and Sarveshwar Foods Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Ajanta Pharma Limited financial statement analysis. It represents the amount of money remaining after all of Ajanta Pharma Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Ajanta Pharma Competitive Analysis

The better you understand Ajanta Pharma competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ajanta Pharma's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ajanta Pharma's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AJANTPHARM KOHINOOR MEDIASSIST SARVESHWAR LTFOODS VERTOZ ADFFOODS FOODSIN
 1.00 
 3,027 
Ajanta
 1.03 
 40.54 
Kohinoor
 2.87 
 568.65 
MEDI
 4.87 
 9.47 
Sarveshwar
 5.28 
 381.50 
LTFOODS
 0.13 
 14.91 
Vertoz
 0.94 
 327.00 
ADF
 1.36 
 119.76 
Foods
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Book Value Per Share
Total Asset
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Ajanta Pharma Competition Performance Charts

Five steps to successful analysis of Ajanta Pharma Competition

Ajanta Pharma's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ajanta Pharma Limited in relation to its competition. Ajanta Pharma's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ajanta Pharma in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ajanta Pharma's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ajanta Pharma Limited, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ajanta Pharma position

In addition to having Ajanta Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ajanta Stock

Ajanta Pharma financial ratios help investors to determine whether Ajanta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajanta with respect to the benefits of owning Ajanta Pharma security.